Accès gratuit
Numéro
Ann. Fr. Med. Urgence
Volume 12, Numéro 2, Mars 2022
Page(s) 129 - 136
Section Actualités en médecine d’urgence / News in emergency medicine
DOI https://doi.org/10.3166/afmu-2022-0399
Publié en ligne 12 mai 2022
  • McDonagh TA, Metra M, Adamo M, et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–726 [CrossRef] [PubMed] [Google Scholar]
  • Kozhuharov N, Goudev A, Flores D, et al (2019) Effect of a strategy of comprehensive vasodilation vs. usual care on mortality and heart failure rehospitalization among patients with acute heart failure: the galactic randomized clinical trial. JAMA 322:2292–302 [CrossRef] [PubMed] [Google Scholar]
  • Vidán MT, Bueno H, Wang Y, et al (2010) The relationship between systolic blood pressure on admission and mortality in older patients with heart failure. Eur J Heart Fail 12:148–55 [CrossRef] [PubMed] [Google Scholar]
  • Smith SW, Dodd KW, Henry TD, et al (2012) Diagnosis of STelevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule. Ann Emerg Med 60:766–76 [CrossRef] [PubMed] [Google Scholar]
  • Meyers HP, Limkakeng AT, Jaffa EJ, et al (2017) Validation of the modified Sgarbossa criteria for acute coronary occlusion in the setting of left bundle branch block: a retrospective case-control study. Am Heart J 170:1255–64 [Google Scholar]
  • Cai Q, Mehta N, Sgarbossa EB, et al (2013) The left bundle-branch block puzzle in the 2013 ST-elevation myocardial infarction guideline: from falsely declaring emergency to denying reperfusion in a high-risk population. Are the Sgarbossa Criteria ready for prime time? Am Heart J 166:409–13 [CrossRef] [PubMed] [Google Scholar]
  • Dawwas GK, Brown J, Dietrich E, Park H (2019) Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis. Lancet Haematol 6:e20–e28 [CrossRef] [PubMed] [Google Scholar]
  • Sindet-Pedersen C, Staerk L, Pallisgaard JL, et al (2018) Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study. Eur Heart J Cardiovasc Pharmacother 4:220–7 [CrossRef] [PubMed] [Google Scholar]
  • Collet JP, Thiele H, Barbato E, et al (2021) 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 42:1289–367 [CrossRef] [PubMed] [Google Scholar]
  • Roffi M, Patrono C, Collet JP, et al (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 37:267–315 [CrossRef] [PubMed] [Google Scholar]
  • Stepinska J, Lettino M, Ahrens I, et al (2020) Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association. Eur Heart J 9:76–89 [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.